Atul Malhotra, MD

Solriamfetol Treatment of Excessive Daytime Sleepiness in Participants With Narcolepsy or Obstructive Sleep Apnea With a History of Depression

Background: Depression is commonly comorbid with narcolepsy and obstructive sleep apnea (OSA). Solriamfetol (SunosiTM), a dopamine/norepinephrine reuptake inhibitor, has been approved in ...

Lawrence Lee , PhD;

Russell 1022962 , PhD;

Atul Malhotra , MD;

Paula Schweitzer , MD, PhD;

Kimberly Babson , PhD;

Shay Bujanover , MD;

Kingman Strohl , MD;

Ruth Benca , MD, PhD;

11/22/2019

Long-Term Safety and Maintenance of Efficacy of Solriamfetol (JZP-110) in the Treatment of Excessive Sleepiness in Participants With Narcolepsy or Obstructive Sleep Apnea

INTRODUCTION: Excessive sleepiness (ES) is a prominent symptom of narcolepsy and obstructive sleep apnea (OSA). Solriamfetol, a selective dopamine/norepinephrine reuptake inhibitor, was e...

Colin Shapiro , PhD, FRCPC, MBBCh;

Richard Schwab , MD;

Jean-Louis Pepin , MD;

Jan Hedner , MD;

Mansoor Ahmed , MD;

Nancy Foldvary-Schaefer , DO, MS;

Patrick Strollo , MD;

Geert Mayer , MD;

Kathleen Sarmiento , MD, MPH;

Michelle Baladi , PhD;

Patricia Chandler , MD;

Lawrence Lee , PhD;